Table 2. Characteristics of the study subjects with endometrial adenocarcinoma (EAC).
| Clinicopathologic features | Number | Percentage (%) |
|---|---|---|
| Age (years) | ||
| <60 | 33 | 33.7 |
| ≥60 | 65 | 66.3 |
| Tumor size (cm) | ||
| <5 | 28 | 28.6 |
| ≥5 | 70 | 71.4 |
| Tumor site | ||
| Upside | 55 | 56.1 |
| anterior and posterior | 43 | 43.9 |
| Pathological type | ||
| adenocarcinoma | 54 | 55.1 |
| adenocarcinoma with dysplasia | 44 | 44.9 |
| Pathological grade | ||
| I | 19 | 19.4 |
| II | 9 | 9.2 |
| III | 70 | 71.4 |
| Tumor invasive depth | ||
| T1 + T2 | 52 | 53.1 |
| T3 + T4 | 46 | 46.9 |
| lymph node metastasis | ||
| negative | 36 | 36.7 |
| positive | 62 | 63.3 |
| Distant metastasis | ||
| M0 | 41 | 41.8 |
| M1 | 57 | 58.2 |
| Tumor stage | ||
| I | 11 | 11.2 |
| II | 26 | 26.5 |
| III | 31 | 31.6 |
| IV | 30 | 30.7 |
| Follow-up time (months) | 12–84.5 | |
| Prognosis | ||
| alive | 32 | 32.7 |
| dead | 58 | 59.2 |
| unknown | 8 | 8.1 |
| patients lived for ≥ 5 years | 52 | 53.1 |
| patients lived for < 5 years | 42 | 42.9 |
| Unknown | 4 | 4.0 |